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ORIGINAL ARTICLE 
Arrhythmia/Electrophysiology 
Optimal Strength and Number of Shocks at Upper 
Limit of Vulnerability Testing Required to Predict 
High Defibrillation Threshold Without 
Inducing Ventricular Fibrillation 
Kaol1J Takam i. MD; Akihiro Yoshida, MD; Koji Fukuzawa, MD; Asumi Takei, MD: 
Kunihiko Kiuchi. MD: Gaku Kanda. MD: Hiroyuki Kumagai , MD: Mil uru Takami. MD; 
Satoko Torii -Tanaka. MD: Mit 'uaki hoh. tiD: Kimitake Imamura, MD; 
Ryudo Fujiwara, MD; At. ushi Suzuki MD; Tomoyuki Nakanishi , MD; 
Soichiro Yamashita, MD; Akinori Mat ·umoto. MD: Ken-ichi Hirata, MD 
Background: The upper limit of vulnerability (UL V) closely correlates with the defibrillation threshold (OFT). The aim 
of th is study was to establish the optimal protocol for using the UL V test to predict high OFT (>20 J) without inducing 
ventricular fibrillation (VF) . 
Methods and Results: The 10-J and 15-J ULV test with 3 coupling intervals (-20, 0, and +20ms to the peak of 
T-wave) and the OFT test were performed in 96 patients receiving implantable cardioverter defibrillator. ULV ::; 10J 
was confirmed in 47 (49%). ULV ::;15J was confirmed in 70 (77%) of 91 patients (15-J ULV test could not be done 
in 5). The sensitivity and negative predictive value of both ULV > 1 OJ and> 15J for predicting high OFT were 100%. 
The specificity and positive predictive value of ULV > 15 J were higher than those for ULV > 1 OJ (85% vs. 55%, 43% 
vs. 22%, respectively). The rate of VF inducibility for confirming ULV ::;15J was lower than that for ULV ::;10J (23% 
vs. 51 %, P<O. OOOI ). On analysis of single 15-J ULV test only at the peak ofT-wave, VF was not induced in 79 of 91 
patients, but 4 of these had high OFT. 
Conclusions: The 15-J ULV test with 3 coupl ing intervals could correctly identify high-OFT patients and reduce the 
necessity for VF induction at defibrillator implantation. (Cire J 2013: 77: 2490-2496) 
Key Words: Defibrillation ; Defibrillation threshold; Implantable cardioverter defibrillator; Upper limit of vulnerability: 
Ventricular fibrillation 
I mplantable cardioverter defibri lI ators (ICOs) are estab-lished as the optimal approach to prevent sudden cardiac death due to malignant entriclliar arrhythmias.1- .l And 
cardia reo ynchron ization therapy combined with ICD (CRTD) 
ha~ been indicated in patients with advanced heart fail ure a~­
sociated wiLh electrical and/or mechanical dyssynchmny.+-7 At 
the time of implantation . an ICD genera ll y has to be teo ted to 
en lire that it can re liably sen. e ventricular fibrillation (VF) and 
deLi ver a direct-current shock wi th an acceptable safety margin 
to tenninate Lhe VF once or twice. This test. however. require~ 
repetitive VF induction and thus h~ potentially life-t hreateni ng 
complications.8- lI Therefore. dcfibrilla tion testing wi th mini -
ma! ri~k i ' req uired. 
The upper limi t of vul nerabi lity (U L V) i. the weak~ t shock 
strengt h at whi ch VF ca n no longer be induced when a shock i. 
delivered during the cardiac vulnerable period. A close correla-
tion between the ULV and the defibri llation threshold (OFT) 
has been validated in some studies of humans and other ani-
mals. 1 2- 1~ and the safety and reliability of ICD implantation 
and programming of the lower first -shock strength using vul-
nerability testing without F induction a. a surrogate for 01-1 
as. essment has been demon ·trated .I5--21 
The present study eval uated Lhe usefulness of vu lner..lbili ty 
testing to confirm acceptable DFT at the time of ICD implan-
tation and to predict high OFT (>20J). Optimal strength and 
number of shocks at LV testing to predict high DFT wi thout 
inducing VF were assessed . 
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Upper Limit of Vulnerability Test 2491 
15J < ULV 
High OfT 9/21 
I. 
C no VF, 
10J < ULV S 15J 10 pts 
I 
HIgh OFT 2/5 
.1 
UlV test was started at lOJ 
In early enrolled 49 pts 
VF, 10 pts #3 
no VF, 37 pts 
10J ULV test 
ULV s 10J 
HIgh OFT 0/47 
no VF, 24 pts 
ULV test was started 
at 15J in the next 47 pts 
E 
10J < ULV S 15J 
HIgh OFT 0/13 
Figure. Protocol for vulnerability and defibrillatIOn test, and patient flow. (#1 ) The vulnerability testing was started at 10J in the early 
enrolled 49 patients. VF was induced at 10J in 26 patients (53%; ULV > 10J) and not induced in 23 (47%; ULV S10J). Among the 26 
patients in whom VF was induced at 10-J ULV test , 21 of them underwent testing at 15J . Among these 21 patients, the 15-J vu lner-
ability test induced VF in 11 patients (ULV > 15J) and (C) d id not induce VF in 10 pat ients (10J< ULV S15J) But (#2, B) 15-J ULV 
test could not be done in 5 patients because of their unstable hemodynamics (hypotension or bradycardia) after VF defibrillation. 
(#3) The ULV test was started at 15J in the next 47 patients. VF was induced at 15J in 10 patients (21 %; ULV > 15 J) and not induced 
in 37 (79%; ULV SI 5J) . The 1O-J ULV test was done in the 37 patients with ULV :S;15J . VFwas induced at (El 10J ULVin 13 patients 
(35%; 10J< ULV :S;15J) and VFwas not induced in 24 pat ients (65%; ULV :S; 10J). Accordingly, in all of the 96 patients, (A) ULV s 10J 
was confirmed in 47 patients (49%) and (B-E) ULV >10J was confirmed in 49 patients (51%). With regard to the ULV :s; or >15J, it 
was able to be decided in 91 patients. Of these, (A ,C,E) ULV s 15J was confirmed in 70 patients (77%) and (0 ) ULV >15J was 
confirmed in 21 patients (23%). OFT, defibrillation threshold: PIs , patients; ULV, upper limit of vulnerability; VF, ventricular fi brillation. 
High OFT defined as >20J 
Methods 
Patients 
The . ubjecL~ con. isted of 96 pat ient s (80 men, 16 women) lIn-
dergoing implantat ion of an )CD/CRTD for the first time (n= 75 ) 
or as a replacement (n=2 1) between March 2006 and ovember 
2008. All palients underwent transthoracic echocardiography 
and routine laboratory testing, and all patient. · gave Wli llen in-
fomled consent before the device implantation. 
Device Implantation 
Patienls were ane. thetized with propofo l or mida7olam. Heart 
rhythm . en saturation. and continuolls sy ·temic blood pressure 
were moni lored througho ut all procedure . . Di. po. able adhesive 
defibrillator pads were applied 10 (he patien ts and artached (0 
the external defibrillator for re cue cardioversion . Yariou. de-
Ilbrillator models were implanted. The defibri ll ator . y. tem was 
insened th rough a left pectoral incision in all pat.ients except for 
3 who had a hislOry of device infection (n=) ) and dialy is va!>Cu-
lar access (n=2). The tip o f the ventricular shock lead was placed 
at or near the right ventricular apex if the R wave was ~ m V 
and lhe pacing thre hold was :S; 1.5 mY al 0 .5 ms. Before defibri l-
lator replacement. previously impl<mted shock leads were con-
finncd to sali sfy all the aforemelllioned cri teria. 
Determination of Vulnerable Period 
During right ventricu lar paci ng with a cycle length (Cl) of 
• 500 illS via the shock lead, the l ate~1 peak of the monopha ' ic T-
wave was determi ned on standard 12-lead electrocardiography 
(ECG) displayed at I OOmm/s, and the illlerva l fro mlhe stimulus 
to the lalest peak of lhe T-wave (St-T peak inlerval) was mea-
sured . A limb-lead ECG was substituted if a 12-lead ECG was 
unavailable. The vulnerable period was determined from - 20 to 
+20 m. of the latest T peak, as described. rs.!! 
Definition of Ventricular Fibrillation 
Arrhythmias wi dl CL <280 ms widl polymorphic and irregular 
( Cl >40 ms) QRS complexes on surface ECG were cia sified 
a YF. An'hythmias with monomorphic QRS complexe orCL 
>280 m. were defi ned a. ventricu lar tachycardia and excl uded 
from the YF cou nLlJ 
Vulnerability and Defibrillation Testing 
Vulnerability testing was started at 10J in the early enrolled 49 
palient (Figure). The fi rst I OJ T-wave shock was delivered at 
the St-T peak interval after 8 right ventricuIar pac ing beats wi th 
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Table 1. Patient Characteristics 
Variable 
Age (years) 
M/F 
Underlying heart disease 
Ischemic cardiomyopathy 
Non-ischemic cardiomyopathy 
No structural heart disease 
LVEF (%) 
CRTD 
Indication for defibrillator 
VF or cardiac arrest 
VT 
Non-sustained VT 
Anti-arrhythmic drugs 
Amiodarone 
Sotalol 
Class I 
/l-blockers 
ACEI or ARB 
Outcome (n=96) 
63±14 
80/16 
39 
41 
16 
43±18 
15 
32 
48 
16 
22 
15 
7 
4 
70 
70 
Data given as mean±SD or n. ACEI. angiotensin-converting enzyme 
inhibitor: ARB, angiotensin receptor blocker. CRTD. cardiac resyn-
chronization therapy defibrillator; LVEF, left ventricular ejection frac-
tion; VF. ventricular fibrillation: VT. ventricular tachycardia. 
CL=5OO ms. IJ VF was not induced. a sub:-.equent 10-J ~ho{'k was 
delivered at - 20 m. and +20ms to the St-T peak il11erva l. If three 
10-J shocks wi th difk rent timing did not induce VF. we deter-
mi ned that the UL V wa!> $ IOJ. and then subsequent shock~ were 
decreased to 5 or I J. and deli vered ill the same sequence until 
VF was induced. If VF wa: not induced by a seri e.~ of induction 
shocks. VF wa. induced by alternat ive method .. uch as a hi gh 
frequency bur~ t for defibri llati on test ing. 
Vulnerabil ily was tesled at I-min intervals bel ween shock .. 
If VF was induced. defi bri llation wa~ Ie. ted. Five mi nules after 
VF defibrillation. the energy of the next LV teo t shock was 
incrensed to 15 J and de li ered in the ame manner. I I' VF was 
also induced aIlS 1. il was determined that the UL V wm> > 15 1. 
If VF wa~ not induced by any 15-J T-wave shock . . the UL V Wa! 
determined a ' $ 151. 
The aim of this !>tudy was to estimate the OFT withoul induc-
ing VF. The fi rst 10-J T-wave shocks. however. induced Fi n 
many patienL~ (53lk ) usi ng Ih i. pmtocol. -nlerefore. we changed 
the firs t ind uction shock to ISJ in the next 47 p<llients (Figure). 
The pmtocol for the IS-J shocks wa: the same a~ that de. cribed 
for the 10-J . hocks. 
Duri ng defi brillation te. ting for induced VF. we eval uated 
only whether DFT was $20J or nol. TIle fir ,t defibrillation !>hock 
was set at 20J ,md the second was sel at the maximum deli vered 
energy of each device. If the fiN 20-J . hock cou ld not defib ri 1-
late (DFT >20 J). the fi r 'l shock was increa ed by S J unt il VF 
was defi brillated in sub equent ddi brillation tesls. We defi ned 
DFT a. the sma llesl shock slrength that defibri ll ated Iwice . 
In bolh vul nerahility and defibrillation te!'ting. shock energy 
was unified as de li vered energy. Therefore. the programmed 
(charged) energy wa. adjusted to obtain the required deli vered 
energy for the Gu idanl defi brillator (de livered energy of 10. IS 
and 20J wa equi valenlto charged energy of II . 17 and 23J, re-
specli vely). 
If a patient became hemodynamically unstable or fell into VF 
seve ra lt im~ du ring these tests. vulnerability and defi bri llation 
TAKAMI Ketal. 
lesling w~re ~ Iopped according 10 Ihe dec i ~ i on of Ihe operator. 
Statistical Analysis 
Base line characteristic!> are given a~ mean ± SD and were ana-
lyzed for stati stica l significance using pai red t-te t fo r continu-
ous variahles and Fisher's exact te!'.t for calegorical variabl es. 
P<O.OS wa. conside red . tatistica lly . igniflcanl. 
Results 
Tn i)l(' I li ~ t s the pat ient characterislics. Ant i-arrhyth mic drugs 
(amiodaJOne. n= 15 : sotalo!' n= 7: mexi letine. n=2: pirmenoI. 
n= I: procainamide. n= I) were given to 26 patients and f3-blockers 
were given to 70 (73%) at the time of the procedure . 
Device Implantation 
Atlhe time of I D implant ation. the mean R wave amplitude 
on the ventricular sensing lead was 12.6±5. llmV (range. S.O-
29. lmV ). The stimulation thre 'hold was < 1.5 Vat 0.5 nlS in all 
patienL~. Dual-c hamber ICDs and CRTDs were implanted in 73 
and IS patients. respecti ve ly. No m(~or periopemti ve compl iC<l-
li on ~ developed that required add itiona l procedure!>. 
Vulnerable Period 
The Illean St-T peak interval W'b 3SI ±3Sm~. 0 visihle T-wave 
alteman ' developed al right ventricular pacing al 500 ms CL. 
Vulnerability and Defibrillation Testing 
The UL V Ie. I wa started at 10J in the early enrolled 49 pa-
tient. (Figure). VF was induced at 10J in 26 patient. (S3%: 
LV > IOJ) and not induced in 23 (47'k: ULV $ IOJ ). Among 
the 26 patienls in whom VF was induced al IO-J UL V test. 21 of 
them underwent te 'Iing at IS J. Among these 21 patients. the IS-J 
LV tesl induced VF in II patients ( LV > IS J) and did nOI 
induce VF in 10 patients ( I 01< LV $ 151: Fib'lJre C). But the 
15-J LV test could not be done in S patient~ hecaLC e of unstable 
hemodynamics (hYJXltension or bradycardia) alier VF defibrilla-
tion. Interestingly. 2 of lhese S palien L~ had high DFT (Figure B). 
The UL V test wa. staned at 15J in the nexl 47 patients 
(Figure). VFwas induced by IS-J ULV test in 10(2 1%: LV 
>15J) lUld nol induced in 37 (799(: ULV $ ISJ). The LV test at 
10J was done in the 37 patienl~ with ULV $ 151. VF was induced 
by 10J LV in 1 3pa[i enL~(35'7c : 1 0 1< ULV $ 1 5 J : Fi~ureF. ) 
and VF was not induced in 24 patients (65%: ULV $ IOJ). 
Among the 47 patients without VF induction on the IO-J LV 
te,~t. 39 pati ent~ underwent the S-J UL V t e,~t and VF w~ induced 
in 28 patients (S J< LV $ IOJ). The I-J ULV le. t was done in 
19 patients ( II patient · without VF inducti on by the S-J LV 
test and 8 patients who did not undergo the S-J LV test) and 
VF w,c induced in 17 paLients ( 11< ULV ~5 J in 10 pa t ient ~ and 
11< UL V $ 1 OJ in 7 pati ent ). In the remaining 2 patients. high 
frequency burst pacing was required for indu 'ing VF. 
UlV and High OFT 
In all of the 96 patients. UL V $ 1 OJ wa ' confimled in 47 patients 
(49o/c; Figure A) and LV > I OJ was confi rmed in 49 patients 
(Sl lff: Figure R- E). In tOlal, II pati enL~ ( II o/e) had high DFT 
(>20J) and ULV wa~ > 10J in all of these II patients. In 38 of 
49 patient.: with ULV > 10J, however, OFT was <20 J (accept-
able DFT). The sensi ti vity • . peci lk ity. pos it ive predicti ve value 
(PPV) and negative predicti ve alue( PV)of LV > IOJfor 
predicting high DFf were 100%. SS%. 22o/r and 100'7<, . respec-
li vely (Table 2). 
Becau e 15-J LV test could not be done in S patient 
(Figure B), the decision ,l~ to whether UL V was $ ISJ or > ISJ 
Ctrculalion Journal Vol n , October 2013 
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Table2. Confirmation of ULV s10J and s15 J, and OFT 
OFT s20J OFT>20 J Total 55 5P PPV NPV 
(n) (n) (n) ("!o) ("!o) ("!o) ("!o) 
ULV s10J 47 0 47 
ULV>10J 38 11 49 100 55 22 100 
Total 85 11 96 
ULV s15J 70 0 70 
ULV>15J 12 9 21 100 85 43 100 
Total 82 9 91 1 
tFive patients could not undergo ULV testing at 15J. OFT, defibrillation threshold; NPV, negative predictive value; PPV, 
positive predictive value: SP, specificity: SS, sensitivity; ULV, upper limit of vulnerability. 
Tabl.3. ULV Test at 10J and 15J; VF Inducibility and High OFT (>20J) 
OFT s20J OFT >20J Total 5 5 5P PPV NPV 
(n) (n) (n) ("!o) ("!o) ("!o) ("!o) 
10-J ULV test with 3CI 
NoVF 47 0 47 
VF 31 8 39 100 66 20 100 
Total 78 8 86 
15-J ULV test with 3CI 
No VF 47 0 47 
VF 12 9 21 100 80 42 100 
Total 59 9 68 
15-J ULV test with 1 CI 
NoVF 52 4 56 
VF 7 5 12 55 88 42 93 
Total 59 9 68 
CI. coupling interval. Other abbreviations see in Tables 1, 2. 
Tabl.". Patient Characteristics vs. ULV Level 
Variables ULV s 10J ULV >10J P·value ULV s15Jt ULV>15Jt P-value (n=47) (n=49) (n=70) (n=21) 
Age (years) 63±14 62±14 0.93 62±15 64±11 0.50 
MIF 39/8 41/8 >0.99 58/12 18/3 >0.99 
Underlying heart disease 
Ischemic cardiomyopathy 23 16 0.14 29 8 >0.99 
Non-ischemic cardiomyopathy 16 25 0_10 29 9 >0.99 
No structural heart disease 8 8 >0.99 12 4 >0.99 
LVEF ("!o) 43±17 43±18 0.88 45±1B 38±17 0.10 
LVDd (mm) 57±9 55±14 0.38 55±10 57±16 0.51 
LVOs (mm) 44±12 42±17 0.51 42±13 45±19 0.35 
CRTD 4 11 0.09 8 5 >0.99 
Anti-arrhythmic drugs 14 12 0.65 20 6 0.59 
Il·blockers 36 34 0.49 53 13 0.27 
ACElorARB 37 33 0.25 51 14 0.17 
St-T peak interval (ms) 349±34 353±35 0.58 348±33 353±37 0.55 
DFT ~20J 0 11 0.0005 0 9 <0.0001 
Data given as mean±SO or n. Five patients could not undergo ULV testing at 15J. LVOd, left ventricular end-diastolic 
dimension; LVDs, LV end-systolic dimension: St-T, stimulus-T wave. Other abbreviations see in Tables 1. 2. 
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wa. made in91 pOltient. . ULV $ 15J was confirmed in 70 pa· 
tiellls (77%: Figure A.eE) and LV > 15 J was confirmed in 
21 patielll (23%: Figure D). A high DF r was not found ill 
patients with UL V $ 15 J. whereas 9 of 21 patielllS with LV 
>15J had a high DFf. The ·ensitivity. specificit y. PPV and 
The ra te of YF inducibi lity to confi rm LV ::; 15J wa. lower 
than that for ULV $ IOJ (23% S. 51 0/(', P<O.OOO I). 
PV of LV> 15 J for predicting high DFf were I OO~ , 85~ . 
43% and 100%. respectively (Table 2). 
10-J ULV vs. 15-J ULV Test 
A total of 86 patients underwent IO-J ULY test and VF was in· 
duced in 39 patient!> (45%; Table ] ). And 68 patiellls underwent 
15-J ULV test and VF was induced in 21 patients (3 1%). The 
Clrculallon Journal Vol 77, October 2013 
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Table 5. Patient Characteristics VS. Presence of High OFT 
(>20J) 
Variables OFT ~20J OFT >20 J P-value (n=85) (n=ll ) 
Age (years) 62±14 66±11 0.35 
MfF 72113 813 0.39 
Underlying heart disease 
Ischemic cardiomyopathy 36 3 0.52 
Non-Ischemic cardiomyopalhy 33 8 0.05 
No structural heart disease 16 0 0.20 
LVEF ('Yo) 44±18 33±17 0.05 
LVDd (mm) 55±11 63±16 0.05 
LVDs (mm) 42±14 51 ±19 0.Q7 
CRTD 12 3 0.37 
Anti-arrhythmic drugs 23 3 >0.99 
J3-blockers 62 8 >0.99 
ACEl or ARB 60 10 0.28 
St-T peak interval (ms) 349±34 367±39 0.10 
Data given as mean±SD or n. Abbreviations see in Tables 1. 2. 4. 
sen~i l ivi l y and TPV or VF ind ucibilil y for both the 10-J and 
15-J ULV te~t forpredi Ling high OFT were lOO%. lmportalllly. 
the spedficity and PP of VF inducibil ity for the 15-J UL V test 
were higher than tho. e for the 10-J ULV te. t (Tahle 3). Fur-
thermore. the rate of VF inducibi lity for Lhe 15-J UL V test was 
lower than that for the 10-J ULV test (3 1 '7r vS. 45'ff . P=O.07). 
Patient Characteristics and ULV 
Patient l'haracte ri s tic~ did not differ ·igni fil.:ant ly belween ULV 
~ I OJ and >1 OJ. and LV ~ IS J and > IS 1. Patients with high 
OFT. however. were more often identi fied with UL V > I OJ than 
~ IOJ (P=0.OOO5). and with ULV > ISJ than ~ 15J (P<O.OOO I; 
Table .t ). 
Optimal Number of Shocks at ULV Test 
We del ivered,) 'hocks within the vulnerable period (-20. O. 
+20 ms to the peak of T-wave wave). The effec tiveness of the 
15-J UL test wi Lh ~ing le shock only at Lhe peak of Lhe T-wave 
wa. ana lyzed. VF wa~ induced hy single shock at 15J in 12 of 
68 patients. and a high Off was found in S (42~ ) of the~e 12 
patients. Among S6 patjents without VF induction by the single 
IS-J ULV test. 4 patients (7.1 %) had a high OFT. The sen. itiv-
ity. specificity. PPV :lI1d PV of VF inducibility by ~i ng l e 15-J 
shock forpredicting 'a high OFrwere 55~ . 88%, 42~ and 93%, 
respective ly (Tahle .' ). The . ensiti vity of single 15-J UL V test 
was con ' iderably lower than that for the 15-J U LV te t with 3 
coupling intervals, and the NPV of ~ing le UL V test was < I 00%. 
Defibrillation Testing and High OFT 
The ICO immediately . enseu VF in all patient. during defi -
brillation te~ting. and the R wave was not under-sen~d during 
F e\'en when sensi tivity was sufficiently blunted. Induced 
F cou ld not be te rminated by a firs t rescue 20-J . hock in I I 
patients (high OFT). System modification such as repo:irion-
ing of Lhe . hock lead or changi ng of the direction of the sho k 
wave wa. required in 4 of them to ach ieve an adequate OFT 
safety rnargi n (OFr Smax imum device output energy- I OJ). 
PreVl~ence of non-ischemic cardiomyopaLhy (P=O.OS). lower 
left ventricular (LV) ejection fraction (P=O.05).larger LV end-
dia ·tolic and end-systolic di mension (p=0.05 and 0.07, respec-
tively) were more common in patients wiLh hi gh Off but Lhe 
TAKAMI K et al. 
uitlerence~ did not reach ~ignifican e (Tahle 5). 
Number of Induction Shocks and Procedure Duration 
The mean number of indul.:tion T-wave shock. was 5.7±2.3: the 
total duration of the test was 14.2±2A min and the amount of 
time required to confinn effective defibri llat ion energy (twice) or 
acceptable LV (~ I Oor S I S .I ) Wa! 6.2±4.7 min for all pati enl~. 
Complications 
ei ther major compl iealions nor prolonged unstahle hemody-
namil.:~ requiring inotropiC agent s or mechanica l ~uppurt were 
encoun tt'red in thi s ~eJi es. 
Discussion 
The major fi nding ' can be summarized as follows . The UL V 
test at JO and 15J is a reli able method to identi fy patients wi th 
;In acceptable OFT (gOJ). In patients wi th acceptable Or:T, the 
rate of VF inuucibility by 15-J LV test was signitkantly lower 
than that for tJ1e 10-J ULV test. Single LV test at the peak of 
T-wave ~ometillles undere. timated the LV . Basel ine patient 
characteri tics could not predict hi gh OFf. but ULV could. 
Ba eu on these find ing '. the 15-J L te t with 3 coupling 
intervals (-20, O. and +20ms to the peak ofT-wave) waS thought 
to be a re liable method to ident ify high-OFT patents without 
inducing VF. 
Previous Reports 
To date. a close correlatjon between the LV and OFr at the 
time of defibrillator implantation ha~ been reported l 2- 14 These 
findi ngs suggest that vu lnerahility testing can be safely and re li -
ably suhstituted for conventional defihrillation tes ti ng. Regard-
ing device implantation without induction of VF. Lhe IS-J LV 
test W~L~ more feas ible compared wiLh Lhe 10-J UL V test. Hwang 
et a l showed that the ULV Wa! <?OJ in 7S% of 60 pati enl~ . and 
all of them had OFr <OOJ.24 Swerdlow et al howed that indue-
tionles implantation i ~ feasible in >80% of patient based on 
vulnerability testing at 151.25 
111e ASSURE study compared vulnerabi lity ale ty margin 
testing vS. defibrillation safery margin test wi th a . ingle VF in-
dUl.:tionldefi brillation: T5 14-J vulnerabi lity testing with 3 cou-
pling intervals was carried out in 420 patient s. VF was not in-
duced in 322 patients (76.70/, ) and defibrillation \Va. achieved 
wi Lh _ I-J shocks in 317 of them (98.4%). Among Lhe 98 patients 
(23.3 o/r ) in whom VF was induced at 14-J vulnerabi lity teo ting. 
21 (2 I Ao/r ) had OFT >2 11. The predictive alue of VF induc-
ibility fur detecting high OFr in the present study was compara-
tively higher than that of ASSURE. The ICO device produced 
by Guidant Wa! used in Lhe ASS RE study. In the Guidant ICO 
~y tem. the programmed energy of 14J i convened into 12J at 
~ hock deliveT)' and tJ1e programmed energy of 2 1 J i convel1ed 
into 18 J at shock deli very. Vulnerabi lity test at " 121" in the 
ASS RE stud . eems to be a reason for lhe relati vely lower 
predictive value of VF inducibility for detectin g high OFT. 
Determination of Vulnerable Period and Underestimation 
of ULV 
The vulnerable zone was defined as a combination of coupl ing 
interval. and the strength of the T-wave shock. It is shown as a 
2-0 , diamond-shaped space defi ned by the coupling interval on 
the absc i'sa and shock strength on the ordinate.26 werdlow 
et al inves tigated the timing of the peak of the human vulner-
able zone using right ventricular pacing at a CL of 500ms and 
~howed that the peak of the human vulnerable LOne is narrow 
lllld includes a median of only two 20-ms intervals . I.' They re-
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ported Ihat a lO-ms difference could cause undereslilllaliun of 
lhe L . and Ihe mo '1 reliable method to define the LV i ' to 
scan the vulnerable period of the T-wave . hock wirhin a windO\ 
of 40 m~ (in lO-ms step) before and after the T-wave peak. We 
delemlincd the vulnerable peliod as a window of 201m before 
and after the T-wave peak . Although Ih is method might under-
eSlimme the LV. none of the pat ients with either UL V ~ JO J or 
~ 15 J hau a hi gh OFf. 
A single T-wave . hock undere,~timares the actua l L V in the 
present study. In the T LIP study vulnerahi lity test was done at 
a si ngle coupling inLerval on the T-wave of lhe ECG lead U.I" 
Although this simplified method reduced the number of required 
induction shocks and the proce-dure lime. the accuracy of mea-
~uring LV might be reduced. 
A T-wave shock was del ivered after ve ntricular pacing al a 
CL of 400m~ in the T ULLP study.'6 Must uf the ULV stud ie~ 
used a hasic CL of 500 ms. Pacing CL might affect the width 
of the vulnerable period. Furthermore. a ~horteneu pacing CL 
mighl cause beal-to-beat in ·tability of repolarization ~uch as 
T-wave alternans. 
Inducibility of VF During Vulnerability Testing 
AU the patients in whom VF was nOI induced by UL V te~t at 
both 10J and 15J had an acceptahle OFf (<?OJ) . And in aJilhe 
patient~ with high OFf. VF was induced by both 10-J anu 15-J 
V tes t. The 10-J and 15-J UL V test. huwever. inuuced VF in 
~ I and in 12 patient s willl acceptable OFf. respectively . The 
higher del ivered energy at ULV teo t Illightlower VF inducibi l-
ity in patients withou t a high OFf. but it might invol ve a risk or 
mi .. ing a high OFf. Further detai led prospecti ve study to iden-
tify the ideal energy at UL V test is required. 
Avoidance of VF induction at defibrill ator implanta tion i~ 
req uired in patients wi th severe heart failure. Unfortunatel in 
these patient ·. VF is likely to be induced even by the vulnera-
bility test. Pati ent. wi th more advanced heart failure were more 
like ly to have high OFT intlle ASSURE study.'s In cOlllras t. 
the parameters or cardiac fun ction 'uch as LV ejection fraction 
and LV dimen~ions did not predict high OFT in the present 
stud .. but L V could predict high OFf. AltllOugh ~ever;11 'lUd-
ies have attempted to identify the predicti ve factors assoc iated 
with hi gh OFT.27-.11 it has been dirficu ltto identify high-OFf 
patients without vulnerability or defibrillat ion testing. 
Study limitations 
The pre. ent study had so me I imitat ions. Shock energy other 
than 10 or 15J might be optimal in vulnerability teo ting. Some 
patients might have a lowerlimit of vulnerabil ity> I OJ or> 15J. 
This likelihood. however. seems to be vanishingly smail because 
none of the pat ient. without VF induced on 10-J ULV te. ting 
had hi gh OFT. 
WithOllt inducing VF. R-wave sensing during induced VF can-
not be ensured. But in patient · with sinus rhythm R·wave sensing 
amplitude >5 mV. R-wave sensi ng dUling VF Wn! thought to be 
aim t always reliable. and critical delay in detecting VF wa~ not 
observed in previous reports.21 
Determination of the vulnerable period u. ing 12- lead ECG is 
e elllial for the UL V test. Thi ' proce require ' ex tra time and 
adequate experience. Recelllly. t.he usefulnes~ uf automated vul-
nerability te. t for predicting high OFT hal been repoJ1ed.21 The 
vulnerable period that was automatically ca l ulated by their ' oft-
ware IVa. well correlated wi th the St-T peak interval. The 18-J 
vulnerability test at 4 coupling intervals could correctly detect 
high-OFT patients wi th 19% of VF inducibilit . The automated 
LV test Illay be able to increase the utility of the L V te~t in 
cl inical practice. 
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Multiple induction shocks might increase OFr. More than 10 
multiple induction shocks were sometimes requireti in the pres-
em srudy. I f these induct ion . hocks increased the OFT. OFT 
might he overestilllated. hut we did not identify a significant 
dissociatiun between UL V and OFT. 
Clinical Implications 
At the time of defi hrillator implantation . the 15-J LV te, t wi th 
3 coupling illlerva is (- 20. O. and +20 ms to the peak of T-wave) 
was thought to be a re li able method to detect high DFf. The 
vulnerable period ~hou ld be detelmined as -:!O. 0 and +10ms to 
the St-T peak interval using multi-Ieau ECG during pacing at a 
CL of 500rns. U' <lily of the 3 T-wave shoc'ks cannot induce VF. 
no further induction is req uireu and implantatiun without VF 
induction C,lIl be completed. 
Although the ULV test can de(.'J'Case the necess ity for VF in-
duction. F tend. to be induced by tht: UL V test in patients willl 
depressed LV function, in whom VF induction is hoped to be 
avoided. Accordingly. we have considered the indication of the 
LV te: t as follows. For the secondary prevemion of . udden 
cardiac death. UL V test should be done. And. if VF i ~ induced. 
Jefibrilla tion safety margin should be ensured. and syslem re-
vision shoulu be done if needed. For primary prevention. the 
UL V I.e ~t mi ght be avoided in patient.~ with . everely depressed 
LV functi on. ImpoJ1antly, the neces. ity of ULV t e~t ~hould be 
decided on a patient-by-pati ent basis. 
Conclusion 
The L test at 10 and 15J witld coupling il1lervals (- 10. O. and 
+20ms to the peak ofT-wave) is a reliable method to identify 
patie nt~ with an acceptable OFT (~20J ). Baseline patient char-
aCleri stics did not predict high-OFT patients. but ULV could 
detect high·OFf patients. For t.he purpo 'e of defibrilla tor implan-
tation without inducing VF, the 15-J LV test was more fea~ible 
than the I O-J te~t. 
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